https://www.selleckchem.com/pr....oducts/gsk2982772.ht
The nonsteroidal anti-inflammatory drug aspirin is an agent of interest for breast cancer prevention. However, it is unclear if aspirin affects mammographic breast density(MBD), a marker of elevated breast cancer risk, particularly in the context of concurrent use of medications indicated for common cardiometabolic conditions, which may also be associated with MBD. We used data from the New York Mammographic Density Study for 770 women age 40-60years old with no history of breast cancer. We evaluated the association between current r
Like
Comment
Share
